Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000133

Chairperson & CEO sold 9,500 shares at an average $514.09 ($4,883,839)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-01 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $135.42 $1,286,490 333,943 I
2026-09-01 Sale : show line 2 in the form 10b5-1 −320 $510.72 $163,432 333,623 I
2026-09-01 Sale : show line 3 in the form 10b5-1 −825 $511.95 $422,359 332,798 I
2026-09-01 Sale : show line 4 in the form 10b5-1 −1,732 $513.12 $888,721 331,066 I
2026-09-01 Sale : show line 5 in the form 10b5-1 −3,454 $514.09 $1,775,676 327,612 I
2026-09-01 Sale : show line 6 in the form 10b5-1 −1,620 $514.98 $834,272 325,992 I
2026-09-01 Sale : show line 7 in the form 10b5-1 −1,469 $516.03 $758,049 324,523 I
2026-09-01 Sale : show line 8 in the form 10b5-1 −80 $516.62 $41,330 324,443 I
Open-market sales · 9,500 sh · avg $514.09 · $4,883,839

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-09-01 Exercise or conversion : show line 9 in the form 10b5-1 Stock Option −9,500 18,410 I
Loading xslF345X06/primarydocument.xml…